IRadimed Corporation
IRMD
$85.27
$0.520.61%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -9.69% | 15.52% | -3.42% | 23.19% | -8.93% |
| Total Depreciation and Amortization | 19.52% | -0.78% | 84.92% | 6.96% | -0.61% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -80.25% | 279.57% | 159.67% | -65.76% | 109.27% |
| Change in Net Operating Assets | 135.84% | -1,871.81% | -84.69% | 197.57% | -800.14% |
| Cash from Operations | 39.97% | -15.22% | -9.81% | 80.48% | -28.31% |
| Capital Expenditure | -36.98% | 74.14% | 56.84% | 28.71% | -32.50% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 45.99% | 2.94% | 33.03% | 14.55% | 17.54% |
| Cash from Investing | -12.63% | 67.05% | 55.25% | 27.91% | -28.14% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 97.84% | -7,735.14% | 69.17% | 17.24% | 78.61% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 70.12% | -295.56% | -0.05% | 0.02% | -13.74% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 76.03% | -396.00% | 2.90% | 0.90% | 5.77% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 197.16% | -252.03% | 32.48% | 240.04% | -470.88% |